The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
COVID-19 vaccine hesitancy and related fears and anxiety
Open accessAbstract
Background Vaccination is crucial to limit the pandemic spread of SARS-CoV-2/COVID-19. Therefore, besides the development and supply of vaccines, it is essential that sufficient individuals are willing to get vaccinated, but concerning proportions of populations worldwide show vaccine hesitancy. This makes it important to determine factors that are associated with vaccine acceptance. Methods 1779 adults of a non-probability convenience sample in Germany were assessed with an online survey in a cross-sectional survey period from 1st to 11th January 2021 (a few days after the beginning of vaccinations in Germany). Results 64.5% of the sample stated that they absolutely would accept the vaccination, 13.8% would rather accept it, 10.4% were undecided, and 5.2% would rather not and 6.0% absolutely not get vaccinated. COVID-19-related anxiety, and fears of infection and health-related consequences correlated significantly positively with vaccine acceptance (all p < .001). In contrast, social (p = .006) and economic fears (p < .001) showed significant negative associations with vaccination willingness. The broader constructs of unspecific anxiety and depressive symptoms were not significantly associated with vaccine acceptance. Vaccine acceptance differed between users/non-users of social media and official websites to gain information about the pandemic (p < .001). Conclusions COVID-19-related anxiety and health-related fears were associated with higher vaccine acceptance, whereas the fear of social and economic consequences showed the contrary direction. These findings highlight the need to differentiate between several types of fears and anxiety to predict their influence on vaccine acceptance, and provide important information and an essential base for future studies and interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Löwe, B., Wahl, I., Rose, M., Spitzer, C., Glaesmer, H., Wingenfeld, K., Schneider, A., & Brähler, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.019 · Cited by 2,473
Functional Fear Predicts Public Health Compliance in the COVID-19 Pandemic
Harper, C. A., Satchell, L. P., Fido, D., & Latzman, R. D. (2021) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00281-5 · Cited by 1,564
Determinants of COVID-19 vaccine acceptance in the US
Malik, A. A., McFadden, S. M., Elharake, J., & Omer, S. B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100495 · Cited by 1,540
Schmid, P., Rauber, D., Betsch, C., Lidolt, G., & Denker, M.-L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170550 · Cited by 1,228
Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults
Fisher, K. A., Bloomstone, S. J., Walder, J., Crawford, S., Fouayzi, H., & Mazor, K. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3569 · Cited by 1,189
Social media and vaccine hesitancy
Wilson, S. L., & Wiysonge, C. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-004206 · Cited by 972
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M. D., & Fang, H. (2020) · Vaccines · doi:10.3390/vaccines8030482 · Cited by 971
Freeman, D., Loe, B. S., Chadwick, A., Vaccari, C., Waite, F., Rosebrock, L., Jenner, L., Petit, A., Lewandowsky, S., Vanderslott, S., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720005188 · Cited by 763
Chou, W.-Y. S., & Budenz, A. (2020) · Health Communication · doi:10.1080/10410236.2020.1838096 · Cited by 675
Detoc, M., Bruel, S., Frappe, P., Tardy, B., Botelho-Nevers, E., & Gagneux-Brunon, A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.041 · Cited by 655
Palamenghi, L., Barello, S., Boccia, S., & Graffigna, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00675-8 · Cited by 483
Vaccine confidence in the time of COVID-19
Harrison, E. A., & Wu, J. W. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00634-3 · Cited by 477
Petzold, M. B., Bendau, A., Plag, J., Pyrkosch, L., Mascarell Maricic, L., Betzler, F., Rogoll, J., Große, J., & Ströhle, A. (2020) · Brain and Behavior · doi:10.1002/brb3.1745 · Cited by 440
Self-citationSalali, G. D., & Uysal, M. S. (2022) · Psychological Medicine · doi:10.1017/s0033291720004067 · Cited by 415 · cited 5×
“While the development of a vaccine against COVID-19 was eagerly awaited by the majority of the communities at the beginning of the pandemic, skeptical voices are now becoming louder and rising evidence shows mixed patterns with a worldwide rather decreasing trend of acceptance [2,5,8,10].”
InfluentialBendau, A., Petzold, M. B., Pyrkosch, L., Mascarell Maricic, L., Betzler, F., Rogoll, J., Große, J., Ströhle, A., & Plag, J. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01171-6 · Cited by 376 · cited 2×
“In the analysis we focused on the both most divergent types of media: social media (as a rather emotionally loaded and unfiltered source of information) and official websites of the government and health authorities (probably providing the comparatively highest amount of reliable information) [17].”
Self-citationVaccine Safety: Myths and Misinformation
Geoghegan, S., O’Callaghan, K. P., & Offit, P. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00372 · Cited by 275 · cited 3×
“Already before the pandemic, vaccine hesitancy was named as one of the top ten threats to global health in 2019 by the World Health Organization [9], and this issue grew further in light of the COVID-19 pandemic.”
Key Guidelines in Developing a Pre-Emptive COVID-19 Vaccination Uptake Promotion Strategy
French, J., Deshpande, S., Evans, W., & Obregon, R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165893 · Cited by 199
Vaccine Hesitancy: A Growing Concern
Kennedy, J. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00385-4 · Cited by 173
Bendau, A., Plag, J., Kunas, S. L., Wyka, S., Ströhle, A., & Petzold, M. B. (2020) · Brain and Behavior · doi:10.1002/brb3.1964 · Cited by 168
Self-citationBendau, A., Kunas, S. L., Wyka, S., Petzold, M. B., Plag, J., Asselmann, E., & Ströhle, A. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102377 · Cited by 163
Self-citationBults, M., Beaujean, D., Richardus, J. H., & Voeten, H. A. C. M. (2015) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2014.160 · Cited by 146
Lu, P.-J., Srivastav, A., Amaya, A., Dever, J. A., Roycroft, J., Stanley, M., O’Halloran, A. C., & Williams, W. W. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.016 · Cited by 119
Lemaître, T., Carrier, N., Farrands, A., Gosselin, V., Petit, G., & Gagneur, A. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1549451 · Cited by 96
Gupta, T., & Gupta, S. K. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106717 · Cited by 90
Quantity does not equal quality: Scientific principles cannot be sacrificed
Rzymski, P., Nowicki, M. O., Mullin, G. E., Abraham, A., Rodríguez‐Román, E., Petzold, M. B., Bendau, A., Sahu, K. K., Ather, A., Naviaux, A.-F., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106711 · Cited by 71
Self-citationMolaei, S., Dadkhah, M., Asghariazar, V., Karami, C., & Safarzadeh, E. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107051 · Cited by 54
Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
Hotez, P. J., Cooney, R. E., Benjamin, R. M., Brewer, N. T., Buttenheim, A. M., Callaghan, T., Caplan, A. L., Carpiano, R. M., Clinton, C., DiResta, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00372-x · Cited by 48
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106980 · Cited by 44
Development of the COVID-19-Anxiety Questionnaire and first psychometric testing
Petzold, M. B., Bendau, A., Plag, J., Pyrkosch, L., Maricic, L. M., Rogoll, J., Betzler, F., Große, J., & Ströhle, A. (2020) · BJPsych Open · doi:10.1192/bjo.2020.82 · Cited by 41
Self-citationImmune response scenario and vaccine development for SARS-CoV-2 infection
Mohammad, M. H. S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107439 · Cited by 14
Cited by
Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K., Ratzan, S. C., Parsons Leigh, J., Hu, J., & El-Mohandes, A. (2022) · Nature Communications · doi:10.1038/s41467-022-31441-x · Cited by 449
Cascini, F., Pantovic, A., Al-Ajlouni, Y., Failla, G., & Ricciardi, W. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101113 · Cited by 396
Vaccine Hesitancy: Contemporary Issues and Historical Background
Nuwarda, R. F., Ramzan, I., Weekes, L., & Kayser, V. (2022) · Vaccines · doi:10.3390/vaccines10101595 · Cited by 282
Kherfan, T., & Sallam, M. (2023) · Vaccines · doi:10.3390/vaccines11081386 · Cited by 26
Anxiety and fear of COVID-19 as potential mechanisms to explain vaccine hesitancy among adults
Fadhel, F. H., Sufyan, N. S., Alqahtani, M. M. J., & Almaamari, A. A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1376567 · Cited by 12
“On the Contrary, studies showed that the lower perceived risk of coronavirus infection was associated with vaccine hesitancy (3, 7, 29).”
BackgroundResultInfluential
Metadata
- Authors
- Bendau, A., Plag, J., Petzold, M. B., & Ströhle, A.
- Venue
- International Immunopharmacology
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 97
- Pages
- 107724
- ISSN
- 1567-5769 (ISSN-L)
- OpenAlex
- W3159891593
- Cited by
- 390
- References
- 30
- FWCI
- 44.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.